Literature DB >> 22941016

Fibrolamellar variant of hepatocellular carcinoma.

Yun Shin Chun1, Giuseppe Zimmitti.   

Abstract

The fibrolamellar variant of hepatocellular carcinoma is a rare primary liver cancer occurring in adolescents and young adults without chronic liver disease or known risk factors. Histologically, it is defined by lamellar bands of fibrosis surrounding well-differentiated tumor cells. Radiologic imaging typically demonstrates a large, solitary mass with calcifications and a central scar. Lymph node metastases in the porta hepatis are frequently diagnosed upon presentation. More patients with fibrolamellar carcinoma are candidates for surgical resection than those with conventional hepatocellular carcinoma, owing to their young age and absence of cirrhosis. The most important prognostic factor is surgical resection, which results in 5-year overall survival rates ranging between 50 and 76 %. Despite complete surgical resection, relapse rates are high, and novel therapies are needed to prevent and treat recurrent disease.

Entities:  

Mesh:

Year:  2013        PMID: 22941016     DOI: 10.1007/978-3-642-16037-0_7

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  4 in total

1.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

2.  Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.

Authors:  Suguru Yamashita; Jean-Nicolas Vauthey; Ahmed O Kaseb; Thomas A Aloia; Claudius Conrad; Manal M Hassan; Guillaume Passot; Kanwal P Raghav; Mohamed A Shama; Yun Shin Chun
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

3.  A prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinoma.

Authors:  Kelly J Lafaro; Oliver S Eng; Mustafa Raoof; Philip Ituarte; Susanne G Warner; Gagandeep Singh; Yuman Fong; Laleh G Melstrom
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

4.  Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells.

Authors:  Tsunekazu Oikawa; Eliane Wauthier; Timothy A Dinh; Sara R Selitsky; Andrea Reyna-Neyra; Guido Carpino; Ronald Levine; Vincenzo Cardinale; David Klimstra; Eugenio Gaudio; Domenico Alvaro; Nancy Carrasco; Praveen Sethupathy; Lola M Reid
Journal:  Nat Commun       Date:  2015-10-06       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.